PharmaCyte Biotech Inc PMCB

Healthcare Biotechnology

PharmaCyte Biotech, Inc. is a biotechnology company. It is focused on developing cellular therapies for cancer, diabetes, and malignant ascites based upon a cellulose-based live cell encapsulation technology known as Cell-in-a-Box. Its product candidate is referred to as CypCaps. The Cell-in-a-Box encapsulation technology potentially enables genetically engineered live human cells to be used to produce various biologically active molecules. It is advancing clinical research and development of new cellular-based therapies in oncology and diabetes. It is also focused on developing therapies for pancreatic and other solid cancerous tumors by using genetically engineered live human cells. Its product candidate for the treatment of diabetes consists of encapsulated genetically modified insulin-producing cells. It is also focused on the benefits of the Cell-in-a-Box technology to develop therapies for cancer that involve prodrugs based upon certain constituents of the Cannabis plant.

NDAQ:PMCB - Post by User

PharmaCyte Biotech Inc

Bullboard Posts

Comment by NaturalResourceon Jan 28, 2014 1:36pm

59 Views

Post# 22143169

RE:I'll start this Board

OK, we got that rapid move to 22 Cents+, 0.225 "On The Nose"
Today the Trims and Re-Buys are coming in in the 17-18 Cent Range
The selling around 22 Cent was expected because its the old High, and many exit, mainly those who don't follow stocks or do any DD. Today the Low was 0.171 cents.... 22 Cents will become a New Floor by this weeks end, the way I look at it ---in case anyone is following ---original batch is now at a Cost Basis a tad below 8 cents

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading